Viewing nowCombinationNewcosar Plus Tablet
Losartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.

MFDS item code 201907293 · Approved 2019.10.16 · Insurance code 678601580
Treatment of hypertension not controlled with monotherapy
This medication is used to effectively control blood pressure in patients with hypertension whose blood pressure is not adequately controlled with monotherapy.
○ Adults The usual dose of this medicine is 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily. Doses exceeding losartan potassium 100 mg/hydrochlorothiazide 25 mg per day are not recommended. The maximum blood pressure-lowering effect generally occurs around 3 weeks after the start of treatment. This medicine may be administered with other antihypertensive agents and may be taken with or without food. To minimize adverse reactions, start this medicine when the expected effect has not been achieved with monotherapy. 1. Substitution therapy: Concomitant therapy with individually dose-adjusted losartan potassium and hydrochlorothiazide may be replaced with this medicine. 2. Patients whose blood pressure is not controlled with losartan or hydrochlorothiazide monotherapy: Start with 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. 3. Patients whose blood pressure is not controlled with losartan potassium 100 mg monotherapy: Start with losartan potassium 100 mg/hydrochlorothiazide 12.5 mg once daily. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. 4. Patients whose blood pressure is not controlled with hydrochlorothiazide 25 mg once daily, or who have hypokalemia even when their blood pressure is controlled with this dose: Treatment may be started with 1 tablet of losartan potassium 50 mg/hydrochlorothiazide 12.5 mg once daily, which can reduce the hydrochlorothiazide dose without reducing the overall blood pressure-lowering effect. Thereafter, continue to assess the clinical response to losartan potassium 50 mg/hydrochlorothiazide 12.5 mg. If blood pressure is not controlled after 3 weeks of treatment, the dose may be increased to a maximum of 1 tablet of losartan potassium 100 mg/hydrochlorothiazide 25 mg once daily. ○ Patients with renal impairment The usual dose is administered when creatinine clearance is 30 mL/min or greater. Use in patients with more severe renal impairment is not recommended, as loop diuretics are preferable to thiazide drugs in these patients. ○ Patients with hepatic impairment Use in patients with hepatic impairment requiring dose adjustment is not recommended, as the initial losartan potassium dose of 25 mg for these patients is not available in this combination product.
Children (under 18 years): Since there is no experience with use in children and adolescents, the losartan-hydrochlorothiazide combination should not be administered to children or adolescents.
This medication can cause serious harm or death to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. This medication should not be used by certain patients, such as those who are allergic to it or its components, have very poor kidney function, or have severe liver dysfunction. Patients with specific health conditions such as hypotension, kidney disease, liver disease, gout, or electrolyte imbalances should use this medication cautiously and have regular check-ups as directed by a physician. During the use of this medication, there is a risk of low blood pressure, so if symptoms like dizziness or drowsiness occur, caution is needed, especially when driving or operating machinery. When taken with medications that may affect potassium levels, there is a risk of hyperkalemia; therefore, potassium supplements or salt substitutes containing potassium should not be taken without consulting a physician. This medication can make the skin sensitive to sunlight, so exposure to sunlight should be limited, and if any skin abnormalities occur, a physician should be consulted immediately. Regular tests of blood, liver, kidney function, and electrolyte levels are necessary to detect and manage any abnormal signs early. There is a lack of experience with use in children or adolescents, so it should not be administered to them. Caution is also needed in the elderly due to a higher frequency of adverse reactions. Possible side effects during use include dizziness, cough, rash, myalgia, gastrointestinal disturbances, etc.; if symptoms are severe or persistent, consult a physician. Women who are pregnant or planning to become pregnant should consult a physician before deciding to take this medication, and those who are breastfeeding should also consult a specialist since this medication may be passed into breast milk. In case of overdose, there may be symptoms of hypotension or arrhythmias, so immediate medical attention should be sought for appropriate treatment. This medication must be kept out of reach of children and stored in its original container; transferring it to another container may pose a risk of decreased quality or misuse.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in a container that blocks light. Additionally, it is best to store the medication in a cool room temperature, between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness.
Yellow oval film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
(Co., Ltd.) Yuhan
CombinationLosartan Potassium 100mg · Hydrochlorothiazide 25mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
(Co., Ltd. ) Yuyoung Pharmaceutical
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Youngpoong Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Kolon Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 100mg · Hydrochlorothiazide 25mg
Tablet · Prescription medication · Combination
NBK Pharmaceutical Co., Ltd.
CombinationLosartan Potassium 50mg · Hydrochlorothiazide 12.5mg
Tablet · Prescription medication · Combination
Dongkwang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.